Literature DB >> 32031683

Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.

Sudhir Kumar1,2, Alok K Verma1,2, Richa Rani1,2, Akanksha Sharma1,2, Jiang Wang3, Shimul A Shah4, Jaideep Behari5, Rosa Salazar Gonzalez6, Rohit Kohli6, Chandrashekhar R Gandhi1,2,5.   

Abstract

BACKGROUND AND AIMS: The augmenter of liver regeneration (ALR) protein is critical for lipid homeostasis and mitochondrial function. We investigated high-fat/high-carbohydrate (HF/HC) diet-induced nonalcoholic fatty liver disease (NAFLD) in wild-type (WT), hepatocyte-specific ALR-knockout (ALR-H-KO), and ALR-heterozygous (ALR-H-HET) mice. ALR was measured in serum of human nonalcoholic steatohepatitis (NASH) and NASH-induced cirrhosis (serum and liver). APPROACH AND
RESULTS: HF/HC feeding decreased ALR expression in all groups of mice. The otherwise normal ALR-H-HET mice gained more weight and steatosis than WT mice when challenged metabolically with the HF/HC diet; ALR-H-KO mice gained the least weight and had the least steatosis. These findings were consistent with correspondingly increased triglycerides and cholesterol and altered expression of carnitine palmitoyltransferase 1a, sterol regulatory element-binding protein, acetyl coenzyme A carboxylase, and fatty acid synthase. All HF/HC-fed mice developed insulin resistance, the magnitude being lower in ALR-H-KO mice. HF/HC-fed ALR-H-HET mice were more resistant to glucose challenge than WT or ALR-H-KO mice. The frequency of tumor necrosis factor alpha-producing, interleukin 6 (IL6)-producing, and IL17-producing cells was greater in ALR-H-KO than ALR-H-HET and lowest in WT mice. HF/HC feeding did not increase their number in ALR-H-KO mice, and the increase in ALR-H-HET was greater than that in WT mice except for IL17 cells. Cluster of differentiation 25-positive (CD25+ ) forkhead box P3-positive CD4+ regulatory T-cell frequency was lower in ALR-H-HET than WT mice and further reduced in ALR-H-KO mice; HF/HC reduced regulatory T-cell frequency only in WT mice. HF/HC-fed ALR-H-HET, but not WT, mice developed fibrosis; and ALR-H-KO mice progressed to cirrhosis. White adipose tissue of HF/HC-fed ALR-deficient mice developed strong inflammation, indicating bidirectional interactions with the liver. Hepatic and serum ALR levels were significantly reduced in patients with NASH-cirrhosis. Serum ALR was also significantly lower in patients with NASH.
CONCLUSIONS: Hepatic ALR deficiency may be a critical predisposing factor for aggressive NAFLD progression.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID: 32031683      PMCID: PMC8025692          DOI: 10.1002/hep.31167

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  39 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 2.  Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis.

Authors:  J D Horton
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

Review 3.  The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

Authors:  M S Brown; J L Goldstein
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

4.  High-fat diet overfeeding promotes nondetrimental liver steatosis in female mice.

Authors:  Lino Arisqueta; Hiart Navarro-Imaz; Ibone Labiano; Yuri Rueda; Olatz Fresnedo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-08-10       Impact factor: 4.052

5.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

Authors:  A J Sanyal; C Campbell-Sargent; F Mirshahi; W B Rizzo; M J Contos; R K Sterling; V A Luketic; M L Shiffman; J N Clore
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

6.  An essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in the maturation of cytosolic Fe/S proteins.

Authors:  H Lange; T Lisowsky; J Gerber; U Mühlenhoff; G Kispal; R Lill
Journal:  EMBO Rep       Date:  2001-08       Impact factor: 8.807

7.  Augmenter of liver regeneration: a flavin-dependent sulfhydryl oxidase with cytochrome c reductase activity.

Authors:  Scott R Farrell; Colin Thorpe
Journal:  Biochemistry       Date:  2005-02-08       Impact factor: 3.162

8.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

9.  Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes.

Authors:  Chinnasamy Thirunavukkarasu; Lian Fu Wang; Stephen A K Harvey; Simon C Watkins; J Richard Chaillet; John Prelich; Thomas E Starzl; Chandrashekhar R Gandhi
Journal:  J Hepatol       Date:  2008-01-28       Impact factor: 25.083

Review 10.  Metabolic interplay between white, beige, brown adipocytes and the liver.

Authors:  Ludger Scheja; Joerg Heeren
Journal:  J Hepatol       Date:  2016-01-30       Impact factor: 25.083

View more
  7 in total

1.  The protective effect of selenoprotein M on non-alcoholic fatty liver disease: the role of the AMPKα1-MFN2 pathway and Parkin mitophagy.

Authors:  Jingzeng Cai; Jiaqiang Huang; Jie Yang; Xiaoming Chen; Haoran Zhang; Yue Zhu; Qi Liu; Ziwei Zhang
Journal:  Cell Mol Life Sci       Date:  2022-06-09       Impact factor: 9.261

2.  Mitochondria homeostasis: Biology and involvement in hepatic steatosis to NASH.

Authors:  Yu-Feng Li; Zhi-Fu Xie; Qian Song; Jing-Ya Li
Journal:  Acta Pharmacol Sin       Date:  2022-02-01       Impact factor: 7.169

Review 3.  The Effect of Lipid Metabolism on CD4+ T Cells.

Authors:  Feiyang Cai; Shuxin Jin; Guangjie Chen
Journal:  Mediators Inflamm       Date:  2021-01-05       Impact factor: 4.711

Review 4.  Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies.

Authors:  Tingyu Fang; Hua Wang; Xiaoyue Pan; Peter J Little; Suowen Xu; Jianping Weng
Journal:  Int J Biol Sci       Date:  2022-09-06       Impact factor: 10.750

5.  Augmenter of liver regeneration ameliorates ischemia-reperfusion injury in steatotic liver via inhibition of the TLR4/NF-κB pathway.

Authors:  Junhua Weng; Xin Wang; Baohong Xu; Wen Li
Journal:  Exp Ther Med       Date:  2021-06-10       Impact factor: 2.447

Review 6.  Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

7.  Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway.

Authors:  Tian Lan; Yang Yu; Jing Zhang; Haonan Li; Qiqing Weng; Shuo Jiang; Song Tian; Tonghao Xu; Sha Hu; Guizhi Yang; Yan Zhang; Weixuan Wang; Lexun Wang; Qing Zhu; Xianglu Rong; Jiao Guo
Journal:  Hepatology       Date:  2021-08       Impact factor: 17.425

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.